# 2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

> **NCT04229394** · PHASE1 · COMPLETED · sponsor: **Orient Europharma Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Osteoarthritis (OA) of the Knee

## Interventions

- **DRUG:** 2ccPA
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04229394
- **Lead sponsor:** Orient Europharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-13
- **Primary completion:** 2021-03-22
- **Final completion:** 2021-03-22
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04229394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04229394, "2ccPA Study in Patients With Symptomatic Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04229394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*